Deciphering the immunoregulatory network governing antigen presenting myeloid cells
破译控制抗原呈递骨髓细胞的免疫调节网络
基本信息
- 批准号:10792697
- 负责人:
- 金额:$ 22.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Administrative SupplementAntigen PresentationAwardBiologyCellsComplexDendritic CellsDiseaseEquipmentEvaluationFrequenciesGene ExpressionGoalsHealthHematopoiesisImmuneImmune responseImmunityImmunotherapyInflammationKnowledgeLaboratoriesMacrophageMeasurementMolecularMyeloid CellsParentsPopulationProliferatingPropertyProteinsResearchRoleSamplingSignal PathwaySignal TransductionSystemT cell responseTissuesfunctional outcomesimmunoregulationindexinginsightinstrumentinstrumentationpathogenresponsesuccess
项目摘要
SUMMARY
The goal of this administrative supplement for the parent award R35GM145290 is to purchase a flow
cytometric analyzer system for high-throughput automated sample acquisition and analysis. The equipment will
allow measurement of multiple properties within various investigated immune cell subsets. Readout indices
include assessment of cell population frequencies, proliferation capacities, variances in lineage commitment
and differentiation, altered molecular signaling activities and changes in functional outcomes in response to
pathogen challenges, among other measurements. Briefly, dendritic cells (DC) are responsible for directing T
cell responses and macrophages important for modulating tissue inflammation. A hallmark of these immune
cells is their inherent plasticity in gene expression profiles to govern immunity vs. tolerance. However, much
remains unknown regarding the complex molecular networks that collectively govern hematopoiesis,
inflammation and antigen presentation. Incomplete understanding presents major obstacles to delineating their
underlying roles in health and disease, which has also hindered success in developing effective
immunotherapies. The long-term goal of the proposed research is to determine how pivotal immunoregulatory
proteins govern DC and macrophage differentiation and immune responses in steady-state vs. disease
settings. Acquisition of a flow cytometric analyzer with a universal loader will allow the laboratory to engage in
high-throughput automated sample acquisition to assess multiple indices within samples employing 96- and
384-well plates. Knowledge gained in our studies, with the chief readout instrument being flow cytometric
analysis, will fill key gaps in our understanding of DC and macrophage biology and provide important insights
into the molecular networks governing immunity and tolerance.
概括
家长奖励 R35GM145290 的此行政补充的目标是购买流量
用于高通量自动化样品采集和分析的细胞分析仪系统。该设备将
允许测量各种研究的免疫细胞亚群中的多种特性。读数指数
包括评估细胞群体频率、增殖能力、谱系承诺的差异
和分化、分子信号活动的改变以及功能结果的变化
除其他测量外,还包括病原体挑战。简而言之,树突状细胞 (DC) 负责指导 T
细胞反应和巨噬细胞对于调节组织炎症很重要。这些免疫的一个标志
细胞的基因表达谱具有固有的可塑性,以控制免疫与耐受。然而,很多
关于共同控制造血作用的复杂分子网络仍然未知,
炎症和抗原呈递。不完整的理解给描绘它们带来了重大障碍
在健康和疾病中的潜在作用,这也阻碍了成功开发有效的
免疫疗法。拟议研究的长期目标是确定关键的免疫调节如何
蛋白质控制稳态与疾病状态下 DC 和巨噬细胞的分化和免疫反应
设置。购买带有通用装载机的流式细胞分析仪将使实验室能够从事
高通量自动化样品采集,采用 96- 和
384 孔板。在我们的研究中获得的知识,主要的读数仪器是流式细胞仪
分析,将填补我们对 DC 和巨噬细胞生物学理解的关键空白,并提供重要的见解
进入控制免疫和耐受性的分子网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael W Lipscomb其他文献
Michael W Lipscomb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael W Lipscomb', 18)}}的其他基金
Deciphering the immunoregulatory network governing antigen presenting myeloid cells
破译控制抗原呈递骨髓细胞的免疫调节网络
- 批准号:
10629283 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Delineating the function of MHC class III genes in antigen presenting myeloid cell contribution to autoimmunity
描述 MHC III 类基因在抗原呈递骨髓细胞对自身免疫的贡献中的功能
- 批准号:
10429530 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Delineating the function of MHC class III genes in antigen presenting myeloid cell contribution to autoimmunity
描述 MHC III 类基因在抗原呈递骨髓细胞对自身免疫的贡献中的功能
- 批准号:
10641866 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Deciphering the immunoregulatory network governing antigen presenting myeloid cells
破译控制抗原呈递骨髓细胞的免疫调节网络
- 批准号:
10405313 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Development of tolerogenic dendritic cell-based immunotherapies and restorative insulin approaches to alleviate type 1 diabetes
开发基于耐受性树突状细胞的免疫疗法和恢复性胰岛素方法以缓解 1 型糖尿病
- 批准号:
10189649 - 财政年份:2018
- 资助金额:
$ 22.97万 - 项目类别:
Crosstalk and the cytoskeleton in dendritic cell antigen presentation
树突状细胞抗原呈递中的串扰和细胞骨架
- 批准号:
8795050 - 财政年份:2015
- 资助金额:
$ 22.97万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:














{{item.name}}会员




